IXA next Networking event on March 5
March 5, 2019“Grab a boat into your future” with this title IXA, students entrepreneurship association LEAD and Westpoort association, invited students to a network boat tour. Aim of the event was to connect students to entrepreneurs, active in the Amsterdam harbor area Westpoort.
A group of around 15 entrepreneurs, members of the Westpoort association and thirty students from the recently founded students entrepreneurship association LEAD, boarded for a trip through the Port of Amsterdam.
Several speakers, including LEAD’s boardmember Melanie Malz shared her enthusiasm with the audience and explained how LEAD wishes to be a student association across all faculties and disciplines. LEAD is a student network and support organization for those who want to explore the first steps towards entrepreneurship.
Students from many nationalities and entrepreneurs mingled and exchanged their questions and experience and follow up activities were formulated.
More news
Social enterprise Tony’s Chocolonely and fintech start up SRXP are subject of the newly launched Entrepreneurship Cases
On December 10 the Tony’s Chocolonely and fintech start up SRXP teaching cases were presented to an audience of teachers and entrepreneurs. During his presentation of the SRXP case professor Sustainable Entrepreneurship at VU Amsterdam, Enno Masurel, focused on the development from student start up to a growing and expanding company. While Maarten Hogenstijn researcher […]
News
VU onderzoeker ontvangt €50.000 voor ontwikkelen vriendschapscursus voor eenzame ouderen
VU onderzoeker Tamara Bouwman heeft donderdag 7 maart na een intensieve publiekscampagne voor de Medische Inspirator Prijs de tweede prijs van €50.000 ontvangen voor haar project ‘De online Vriendschapscursus’. Met de prijs gaat Bouwman in samenwerking met cliëntvertegenwoordiger Liesbeth Gaasbeek van de Gouden Dagen de online vriendschapscursus verder ontwikkelen. Uiteindelijk hopen ze de cursus daarmee […]
News
AML patients receive cancer drug DCP-001
DCprime (spin-off VUmc) announces first patient dosed in phase 2 ADVANCE-II study with DCP-001 in patients with Acute Myeloid Leukemia. This administration marks the official start of the phase 2 study in the ADVANCE-II study. A total of 20 patients with acute myeloid leukemia (AML), a rare form of leukemia, participate in this study. A […]
News